Skip to main content
. Author manuscript; available in PMC: 2015 May 24.
Published in final edited form as: Neurosurgery. 2013 Jun;72(6):960–970. doi: 10.1227/NEU.0b013e31828cf619

Table 1.

Demographics and Transplantation Data of 10 Patients with Primary CNS Post-Transplant Lymphoproliferative Disorder.

Characteristic
Sex
 Male 4 (40%)
 Female 6 (60%)

Age at diagnosis of PCNS-PTLD Median 49 years
(Range 38-67 years)

Time from transplantation to PCNS-PTLD Median 4.5 years
(Range 1.8-11.4 years)
 <2 years 3 (30%)
 2-5 years 3 (30%)
 ≥6 years 4 (40%)

Type of transplantation
 Kidney 7
 Kidney/pancreas 3

Indications for transplantation
 Type I diabetes 4
 Hypertensive nephropathy 2
 Focal segmental glomerulonephritis 2
 Interstitial nephritis 1
 Lupus Nephritis 1

Presence of EBV viremia at diagnosis
 Undetectable 1
 <500 copies/mL 4
 500-4000 copies/mL 4
 >5000 copes/mL 1

One patient had undergone repeat transplantation for recurrent focal segmental glomerulonephritis. Data indicate time from most recent transplant to diagnosis of PCNS-PTLD.

Abbreviations: PCNS-PTLD = Primary central nervous system post-transplant lymphoproliferative disorder.